Tarceva Battles Lung Cancer in Some (HealthDay)
HealthDay – THURSDAY, July 21 (HealthDay News) — New research finds that the targeted cancer drug Tarceva nearly triples the amount of time lung cancer patients survive without a recurrence and has fewer side effects than standard chemotherapy.
View full post on Yahoo! News: Health News
Leave a Reply